Recent evidence has identified IL-6, IL-8, and IL-10, alongside acute-phase reactants such as C-reactive protein (CRP) and procalcitonin (PCT), as promising biomarkers for early infection detection in neutropenic patients, supporting timely and targeted therapeutic interventions [3,4]. This evidence concerns the gene IL6 and infection.